Avanos Medical (AVNS) Cash & Equivalents (2013 - 2026)
Avanos Medical (AVNS) posted Cash & Equivalents of $65.6 million for Q1 2026, down 26.95% sequentially from $89.8 million in Q4 2025, and down 32.37% YoY from $97.0 million in Q1 2025.
Avanos Medical (AVNS) Cash & Equivalents (2013 - 2026) Analysis & Trends
Avanos Medical has reported Cash & Equivalents for 14 years, with the latest figure at $65.6 million in Q1 2026.
- Quarterly Cash & Equivalents fell 32.37% year-over-year to $65.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $65.6 million (down 32.37% YoY) and the FY2025 annual result came in at $89.8 million, down 16.62% from the prior year.
- Cash & Equivalents fell to $65.6 million in Q1 2026 per AVNS's latest filing, from $89.8 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $127.7 million in Q4 2022 and troughed at $65.6 million in Q1 2026.
- A 5-year average of $94.5 million and a median of $92.2 million in 2024 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2025 and 2026: Cash & Equivalents grew 27.97% in 2025, then tumbled 32.37% in 2026.
- Over 5 years, Cash & Equivalents stood at $127.7 million in 2022, then plunged by 31.32% to $87.7 million in 2023, then rose by 22.81% to $107.7 million in 2024, then declined by 16.62% to $89.8 million in 2025, then decreased by 26.95% to $65.6 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $65.6 million, $89.8 million, and $70.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 65.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.60 Mn |
| Dec 31, 2025 | 89.80 Mn |
| Sep 30, 2025 | 70.50 Mn |
| Jun 30, 2025 | 90.30 Mn |
| Mar 31, 2025 | 97.00 Mn |
| Dec 31, 2024 | 107.70 Mn |
| Sep 30, 2024 | 89.00 Mn |
| Jun 30, 2024 | 92.20 Mn |
| Mar 31, 2024 | 75.80 Mn |
| Dec 31, 2023 | 87.70 Mn |
| Sep 30, 2023 | 107.10 Mn |
| Jun 30, 2023 | 81.80 Mn |
| Mar 31, 2023 | 95.70 Mn |
| Dec 31, 2022 | 127.70 Mn |
| Sep 30, 2022 | 117.00 Mn |
| Jun 30, 2022 | 106.50 Mn |
| Mar 31, 2022 | 104.30 Mn |
| Dec 31, 2021 | 118.50 Mn |
| Sep 30, 2021 | 97.80 Mn |
| Jun 30, 2021 | 99.90 Mn |